<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03899974</url>
  </required_header>
  <id_info>
    <org_study_id>252/17</org_study_id>
    <nct_id>NCT03899974</nct_id>
  </id_info>
  <brief_title>Metabolic Effects of High-amylose Wheat-based Breads</brief_title>
  <official_title>Metabolic Effects of High-amylose Wheat-based Breads in Overweight Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The amylose-amylopectin ratio influences starch properties. A higher amylose content is
      associated with slower starch digestion thus reducing the postprandial plasma glucose
      response and improving the overall postprandial metabolism. So far, limited evidence is
      available on the metabolic effect of wheat-based foods rich in amylose. This randomised
      controlled study investigated the acute metabolic effects of amylose-rich wheat-based breads
      in overweight subjects focusing on potential mechanisms.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Actual">July 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>2-hours blood glucose response</measure>
    <time_frame>over 2 hours after the test meal</time_frame>
    <description>incremental area under the curve</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>2-hours blood insulin response</measure>
    <time_frame>over 2 hours after the test meal</time_frame>
    <description>incremental area under the curve</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4-hours blood glucose response</measure>
    <time_frame>over 4 hours after the test meal</time_frame>
    <description>incremental area under the curve</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>4-hours blood insulin response</measure>
    <time_frame>over 4 hours after the test meal</time_frame>
    <description>incremental area under the curve</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intestinal fermentation</measure>
    <time_frame>over 4 hours after the test meal</time_frame>
    <description>breath test for the detection of hydrogen production</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glucose response</measure>
    <time_frame>over 2 hours after the standard meal</time_frame>
    <description>Second meal effect</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Postprandial Hyperglycemia</condition>
  <arm_group>
    <arm_group_label>70% amylose bread</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mixed meal with 80g of available carbohydrates coming mainly from high-amylose bread (made with 70% high-amylose flour)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>85% amylose bread</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mixed meal with 80g of available carbohydrates coming mainly from high-amylose bread (made with 85% high-amylose flour)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control bread</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mixed meal with 80g of available carbohydrates coming mainly from conventional bread</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Test meal</intervention_name>
    <description>Participants received in random order the three test meal (700Kcal, 80g available carbohydrates) containing breads prepared with amylose-rich wheat flours (70% or 85%) or conventional flour. Blood samples were collected at fasting and every 30 minutes over 4 hours. Breath hydrogen was evaluated as a marker of intestinal fermentation. Participants underwent Visual Analogue Scale to assess subjective appetite sensations.
After 4 hours, all participants consumed a standard lunch (700 kcal, 100 g available carbohydrates) identical on all the three experimental days to evaluate the &quot;second meal effect&quot; from breakfast to lunch.</description>
    <arm_group_label>70% amylose bread</arm_group_label>
    <arm_group_label>85% amylose bread</arm_group_label>
    <arm_group_label>Control bread</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overweight/obese

          -  18-70 years

        Exclusion Criteria:

          -  age &lt;18 and &gt;70 years;

          -  fasting triglycerides â‰¥400 mg/dl;

          -  fasting cholesterol &gt;270 mg/dl;

          -  cardiovascular events (myocardial infarction or stroke) during the 6 months prior to
             the study

          -  established diabetes mellitus or any chronic disease

          -  renal and liver failure (creatinine &gt;1.7 mg/dl and transaminases &gt;2 times than normal
             values, respectively)

          -  anaemia (Hb &lt;12 g /dl)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Federico II University</name>
      <address>
        <city>Napoli</city>
        <state>Naples</state>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>March 29, 2019</study_first_submitted>
  <study_first_submitted_qc>April 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2019</study_first_posted>
  <last_update_submitted>December 3, 2019</last_update_submitted>
  <last_update_submitted_qc>December 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>rivellese angela</investigator_full_name>
    <investigator_title>Full Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

